These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17065571

  • 41. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ, Anbar RD, Mettelman BB.
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [Abstract] [Full Text] [Related]

  • 42. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.
    Odd DE, Armstrong DL, Teele RL, Kuschel CA, Harding JE.
    J Paediatr Child Health; 2004 Mar; 40(5-6):282-9. PubMed ID: 15151582
    [Abstract] [Full Text] [Related]

  • 43. Antenatal betamethasone: reassuring long-term data.
    Prescrire Int; 2008 Apr; 17(94):73. PubMed ID: 18536142
    [Abstract] [Full Text] [Related]

  • 44. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A, Rizwan S, Waycaster C, Wall GM.
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [Abstract] [Full Text] [Related]

  • 45. Kinetic-dynamic modeling of lymphocytopenia induced by the combined action of dexamethasone and hydrocortisone in humans, after inhalation and intravenous administration of dexamethasone.
    Braat MC, Oosterhuis B, Koopmans RP, Meewis JM, Van Boxtel CJ.
    J Pharmacol Exp Ther; 1992 Aug; 262(2):509-15. PubMed ID: 1501111
    [Abstract] [Full Text] [Related]

  • 46. Early treatment of premature infants with steroids: neurological sequelae.
    Prescrire Int; 2007 Jun; 16(89):108-9. PubMed ID: 17582929
    [Abstract] [Full Text] [Related]

  • 47. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome.
    Schmand B, Neuvel J, Smolders-de Haas H, Hoeks J, Treffers PE, Koppe JG.
    Pediatrics; 1990 Jul; 86(1):58-64. PubMed ID: 2193303
    [Abstract] [Full Text] [Related]

  • 48. Newborn lung treatment poses risk of intestinal perforation.
    J Am Coll Surg; 2001 Mar; 192(3):425-6. PubMed ID: 11245391
    [No Abstract] [Full Text] [Related]

  • 49. Emotional, behavioral, social, and academic outcomes in adolescents born with very low birth weight.
    Dahl LB, Kaaresen PI, Tunby J, Handegård BH, Kvernmo S, Rønning JA.
    Pediatrics; 2006 Aug; 118(2):e449-59. PubMed ID: 16882786
    [Abstract] [Full Text] [Related]

  • 50. Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up.
    Jones R, Wincott E, Elbourne D, Grant A.
    Pediatrics; 1995 Nov; 96(5 Pt 1):897-906. PubMed ID: 7478833
    [Abstract] [Full Text] [Related]

  • 51. [Psychological and neurosomatic follow-up studies of children of mothers treated with dexamethasone].
    Veszelovszky I, Farkasinszky T, Nagy Z, Bódis L, Szilárd J.
    Orv Hetil; 1981 Mar 15; 122(11):629-31. PubMed ID: 7254794
    [No Abstract] [Full Text] [Related]

  • 52. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone.
    Meyer-Bahlburg HF, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI.
    J Clin Endocrinol Metab; 2004 Feb 15; 89(2):610-4. PubMed ID: 14764770
    [Abstract] [Full Text] [Related]

  • 53. Neonatal corticosteroid therapy affects growth patterns in early infancy.
    Tijsseling D, Ter Wolbeek M, Derks JB, de Vries WB, Heijnen CJ, van Bel F, Mulder EJH.
    PLoS One; 2018 Feb 15; 13(2):e0192162. PubMed ID: 29432424
    [Abstract] [Full Text] [Related]

  • 54. Functional outcome at school age of preterm-born children treated with low-dose dexamethasone in infancy.
    Kraft KE, Verhage SE, den Heijer AE, Bos AF.
    Early Hum Dev; 2019 Feb 15; 129():16-22. PubMed ID: 30597329
    [Abstract] [Full Text] [Related]

  • 55. Effect of dexamethasone therapy on pulmonary function in chronic lung disease: a comparison of disease types.
    Mizobuchi M, Manabe C, Yonetani M, Nakao H, Uetani Y, Nakamura H.
    Pediatr Int; 2001 Jun 15; 43(3):226-30. PubMed ID: 11380913
    [Abstract] [Full Text] [Related]

  • 56. Neurodevelopmental impact of hydrocortisone exposure in extremely low birth weight infants: outcomes at 1 and 2 years.
    Patra K, Greene MM, Silvestri JM.
    J Perinatol; 2015 Jan 15; 35(1):77-81. PubMed ID: 25078865
    [Abstract] [Full Text] [Related]

  • 57. The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: a two-year follow-up study.
    Lin YJ, Lin CH, Wu JM, Tsai WH, Yeh TF.
    Acta Paediatr; 2005 Mar 15; 94(3):310-6. PubMed ID: 16028649
    [Abstract] [Full Text] [Related]

  • 58. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study.
    Trautman PD, Meyer-Bahlburg HF, Postelnek J, New MI.
    Psychoneuroendocrinology; 1995 Mar 15; 20(4):439-49. PubMed ID: 8532827
    [Abstract] [Full Text] [Related]

  • 59. Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity.
    Dik WA, Versnel MA, Naber BA, Janssen DJ, van Kaam AH, Zimmermann LJ.
    Eur Respir J; 2003 May 15; 21(5):842-7. PubMed ID: 12765431
    [Abstract] [Full Text] [Related]

  • 60. Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose.
    Dobrowolski P, Tomaszewska E, Muszyński S, Blicharski T, Pierzynowski SG.
    Exp Biol Med (Maywood); 2017 Apr 15; 242(7):671-682. PubMed ID: 28178857
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.